| Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO™ Launch, in Japan |
| Thursday, December 22 2005 | |||
Neptune Technologies & Bioressources Inc. Announces Glucosamine/NKO™ Launch, in JapanLaval Quebec CANADA, December 22, 2005 – Neptune Technologies and Bioressources Inc., is pleased to announce a new Glucosamine/NKO™ blend through a strategic partnership with Koyo Chemical Co., Ltd. This new Joint Health Complex, to be launched in Japan, is a powerful anti-inflammatory and cartilage regenerating formulation comprised with Glucosamine and Neptune Krill Oil (NKO™). The partnership also includes an agreement by which Neptune will exclusively introduce the Joint Health Complex to the North American and European markets. “We are pleased with our agreement with Neptune, allowing us to utilize NKO™ as our main ingredient in our Joint Health Complex product. NKO™, by its anti-inflammatory potency will enhance the Glucosamine benefits for our Japanese consumers. They’ll definitely embrace our new Joint Health Complex with NKO™ inside” said Mr. Taro Terashi, President at Koyo Chemical Co., Ltd. “Additionally our company will benefit from Neptune’s presence and NKO™ recognition, as well as, the popularity of Glucosamine, in the occidental market” added Mr. Taro Terashi. “The Koyo Chemical deal is an important one, they have the most extensive distribution network in Japan, through drug stores, direct sales, retail food chain and health care practitioners which reaches 127 Million consumers,” said Mr. Gang He, Director of Sales, Asia for Neptune Technologies & Bioressources Inc. “More impressively, Koyo Chemical Ltd., was the first ever manufacturer of Glucosamine in Japan, and the first Japanese company to be Food Raw Material GMP certified. The new Glucosamine/NKO™ product, a powerful Joint Health Complex will rapidly cross the Japanese border, as the Neptune Koyo partnership has a reciprocal and mutual agreement, including the opportunity for Neptune to introduce the new the Joint Health Complex with Glucosamine/NKO™, in North America and Europe,” added Mr. Gang He. Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com/ FORWARD-LOOKING STATEMENTS: Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc. Acasti Pharma Inc. Toni Rinow, Ph.D., MBA Corporate Development & Investor Relations (450) 687-2262 This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|